International Symposium Arrhythmogenic Right Ventricular Cardiomyopathy

Size: px

Start display at page:

Download "International Symposium Arrhythmogenic Right Ventricular Cardiomyopathy"

Melvyn Morris
5 years ago
Views:

Invitation and Program International Symposium Arrhythmogenic Right Ventricular Cardiomyopathy Thursday May 31, 2012, 09.00 18.

1 Invitation and Program International Symposium Arrhythmogenic Right Ventricular Cardiomyopathy Thursday May 31, 2012, Hotel Belvoir, Saal Belvoir, Rüschlikon, Switzerland Program Directors Corinna Brunckhorst, Zurich, Switzerland Firat Duru, Zurich, Switzerland Scientific Coordination Ruth Amstein, Zurich, Switzerland

2 Welcome Address Dear colleagues, It is our great pleasure to announce the first international symposium on Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to be held in Rüschlikon, a suburb of the city of Zurich in Switzerland on May 31, ARVC is an important but often underestimated disease affecting about 3500 Swiss inhabitants who are usually diagnosed at a young age and are in need of a lifelong follow-up. In our opinion, given the challenges in the diagnosis and treatment of patients with this heterogeneous disease, more emphasis needs to be given on clinical aspects of the disease and further research studies shall address the remaining questions. Therefore, we have initiated an ARVC Clinical and Research Program in Zurich in 2011 with close collaboration of other centers in Switzerland and abroad. In this context, we have organized this kick-off symposium and are extremely honored to welcome a large Swiss and international faculty of key opinion leaders in this field. The first session is an introduction to ARVC and reveals the background and pathophysiology of this heterogeneous disease. The second session focuses on the diagnostic aspects of the disease and aims to provide helpful insights in approaching the difficult-to-diagnose cases. The third session is dedicated to the therapeutic options in ARVC with expert recommendations for the optimal therapeutic strategy for the individual patient. The last session gives an outlook on future perspectives and current research activities. Last but not least, the platform of this meeting will be used to announce the details of the Georg and Bertha Schwyzer-Winiker Foundation ARVC Research Price, which will be awarded on a regular basis in the upcoming meetings. This symposium is designed for a broad medical audience, ranging from family physicians and clinicians in internal medicine and pediatrics to subspecialists in cardiology, imaging and genetics. Apart from traditional lectures, case-presentations will stimulate an interactive discussion with the aim to provide guidance in everyday practice. Patients with ARVC and family members might benefit from the symposium and are also very welcome to attend. We hope that the program attracts your attention and look forward to spending an interesting and stimulating day on ARVC. Corinna Brunckhorst, M.D. Firat Duru, M.D. Ruth Amstein, PhD. Professor of Cardiology Professor of Cardiology Director Education University Hospital Zurich University Hospital Zurich Foundation for Cardiovascular Research University Hospital Zurich Under the Auspices of Zurich Heart House Foundation for Cardiovascular Research SOCIETAS HELVETICA CARDIOLOGICA The symposium is recognized by the following medical societies as accredited continuing education: Swiss Society of Cardiology (6.5 CME credits category 1A) Swiss Society of Internal Medicine (6.5 CME credits category 1A) German Cardiac Society German Cardiac Society

3 Program Session 1. Introduction to ARVC: An underestimated disease Chairs: R. Jenni, Zurich and E. Delacrétaz, Berne 09:00 Welcome T. F. Lüscher, Zurich 09:05 Opening remarks C. Brunckhorst, Zurich 09:10 ARVC: A not so rare Disease of the Desmosome F. Duru, Zurich 09:30 The multiple facets of ARVCs: From arrhythmias to heart failure G. Fontaine, Paris 10:00 Pathophysiology and mechanistic insights into ARVC M. Delmar, New York 10:30 11:00 Coffee Session 2. Diagnostic perspectives Chairs: Ph. Kaufmann, Zurich and C. Sticherling, Basel 11:00 How to diagnose ARVC: The taskforce criteria F. I. Marcus, Arizona 11:25 The role of imaging in ARVC F. Tanner, Zurich 11:50 Genetics of ARVC: Whom and how to screen? R. Hauer, Utrecht 12:15 Case presentation: Difficult-to-diagnose ARVC L. Haegeli, Zurich 12:30 13:30 LUNCH BREAK Session 3. Therapeutic perspectives Chairs: T. F. Lüscher, Zurich and L. Kappenberger, Lausanne 13:30 Which patients are at high risk? D. Corrado, Padova 13:55 When and how to use which drugs? T. Wichter, Osnabrück 14:20 Device therapy and outcomes H. Calkins, Baltimore 14:45 The role of catheter ablation C. Brunckhorst, Zurich 15:10 Case presentation: Difficult-to-treat ARVC R. Kobza, Lucerne 15:30 16:00 Coffee

4 Program Session 4. Future perspectives Chairs: P. Ammann, St. Gallen and Ch. Attenhofer, Zurich 16:00 Arrhythmias and the risk of sudden death in the athlete C. Schmied, Zurich 16:15 Preventive measures in the world of sports J. Dvorak, Zurich 16:30 Update and discussion on ARVC registries H. Calkins, Baltimore D. Corrado, Padova F. I. Marcus, Arizona T. Wichter, Osnabrück 17:00 Zurich ARVC Clinical and Research Program F. Duru, Zurich C. Brunckhorst, Zurich 17:10 Swiss ARVC Registry A. Saguner, Zurich 17:20 ARVC genetic research in Zurich A. Medeiros, Zurich ARVC Research Price of the Georg and Bertha Schwyzer-Winiker Foundation 17:30 Introduction C. Brunckhorst, Zurich Information on Georg and Bertha Schwyzer- Winiker Foundation ARVC Research Price H-K Schwyzer, Zurich 17:40 Conclusion remarks F. Duru, Zurich

5 Teaching Faculty International Faculty Hugh Calkins, M.D., Johns Hopkins Hospital and Medical Center, Baltimore, MD, USA Domenico Corrado, M.D., University of Padova Medical School, Padova, Italy Mario Delmar, M.D., New York University School of Medicine, New York, NY, USA Guy Fontaine, M.D., La Salpêtrière Hospital, Paris, France Richard Hauer, M.D., University Medical Center, Utrecht, Netherlands Frank I. Marcus, M.D., University of Arizona, Sarver Heart Center, Tucson, USA Thomas Wichter, M.D., Marienhospital, Osnabrück, Germany Swiss Faculty Peter Ammann, M.D., Cantonal Hospital, St. Gallen, Switzerland Christine Attenhofer, M.D., Klinik im Park, Zurich, Switzerland Etienne Delacrétaz, M.D., University Hospital, Berne, Switzerland Jiri Dvorak, M.D., FIFA Chief Medical Officer, Zurich, Switzerland Lukas Kappenberger, M.D., emer., University Hospital, Lausanne, Switzerland Richard Kobza, M.D., Cantonal Hospital, Lucerne, Switzerland Hans-Kaspar Schwyzer, M.D., Schulthess Clinic, Zurich, Switzerland Christian Sticherling, M.D., University Hospital, Basel, Switzerland Local Team Corinna Brunckhorst, M.D., University Hospital, Zurich, Switzerland Firat Duru, M.D., University Hospital, Zurich, Switzerland Laurent Haegeli, M.D., University Hospital, Zurich, Switzerland Rolf Jenni, M.D., University Hospital, Zurich, Switzerland Philipp Kaufmann, University Hospital, Zurich, Switzerland Thomas F. Lüscher, M.D., University Hospital, Zurich, Switzerland Argelia Medeiros, M.D., University Hospital, Zurich, Switzerland Ardan Saguner, M.D., University Hospital, Zurich, Switzerland Christian Schmied, M.D., University Hospital, Zurich, Switzerland Felix Tanner, M.D., University Hospital, Zurich, Switzerland

6 General Information Organisation Zurich Heart House Foundation for Cardiovascular Research Ruth Amstein, PhD. Esther Willi Moussonstr. 4, CH-8091 Zurich Phone +41 (0) , Fax +41 (0) Venue Hotel Belvoir, Saal Belvoir, Rüschlikon, Switzerland Säumerstr. 37, 8803 Rüschlikon, Phone +41 (0) , Registration Registrations have to be submitted online: Registration fee CHF 60. (including scientific program, coffee breaks and lunch) Registration will be confirmed upon receipt of payment. Official Dinner Boat trip on the Lake of Zurich and official dinner at the LakeSide, Zürichhorn, Zurich, starting at Costs: CHF 70. including boat trip, meal and beverages Cancellation Cancellations must be notified in writing (by mail, fax or ) to Zurich Heart House. In case of cancellation up to 1 May 2012, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible. Methods of Payment The fee should be paid in Swiss Francs (CHF) and settled by the following credit cards: VISA or Eurocard/Mastercard. Contact: Esther Willi (esther.willi@usz.ch)

Travel Information Travel by car Take freeway A3 from the center of Zurich in the direction of Chur, exit Thalwil/Rüschlikon, drive 800 meters, take the second exit on the traffic circle entering

7 Travel Information Travel by car Take freeway A3 from the center of Zurich in the direction of Chur, exit Thalwil/Rüschlikon, drive 800 meters, take the second exit on the traffic circle entering Eggstrasse in the direction of Kilchberg, Adliswil, Rüschlikon, drive 550 meters and take the first exit of the circle, exiting to the right entering Feldimoosstrasse. Travel by public transportation Take the S-Bahn train (S8 or S24) at Zurich main train station and ride to Rüschlikon train station. There change to bus 164 and get off at the bus stop «Belvoir». Travel from the airport Take the train to Thalwil (S-Bahn train S2 or Intercity) and there change to the hotel bus (available upon prior request) or change at Zurich main train station and take the S-Bahn train (S8 or S24) to Rüschlikon. There change to bus 164 and ride directly to the Hotel Belvoir, bus stop «Belvoir». ZHH 2012

8 Sponsors Main Sponsors Baard Medica S.A. Logo fehlt Sponsors

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE PCHF POSTGRADUATE COURSE IN HEART FAILURE A novel course in heart failure management Certified by the European Society of Cardiology (ESC) and the University of Zurich. Based on the new curriculum of the